Source: Pearl Pathways Blog

Pearl Pathways Blog Developing a Specialized Drug? Bigger Isn't Always Better When Choosing a CRO

The post Developing a Specialized Drug? Bigger Isn't Always Better When Choosing a CRO appeared first on Pearl Pathways.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Gretchen Miller Bowker's photo - CEO of Pearl Pathways

CEO

Gretchen Miller Bowker

CEO Approval Rating

90/100

Read more